DIPRIVAN

This brand name is authorized in Brazil, Canada, Cyprus, Ecuador, Spain, France, Hong Kong, Ireland, Japan, Mexico, Nigeria, Netherlands, New Zealand, Poland, United Kingdom, United States, South Africa

Active ingredients

The drug DIPRIVAN contains one active pharmaceutical ingredient (API):

1 Propofol
UNII YI7VU623SF - PROPOFOL

Propofol (2, 6-diisopropylphenol) is a short-acting general anaesthetic agent with a rapid onset of action of approximately 30 seconds.

Read about Propofol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
DIPRIVAN Emulsion for injection or infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N01AX10 Propofol N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AX Other general anesthetics
Discover more medicines within N01AX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 505618040043417, 505618040043517, 505618040043617, 505618040043717, 505618040043817, 505618040043917
Country: CA Health Products and Food Branch Identifier(s): 02018950
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 25.364-10-03, 28011-06-09
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 58785, 60744
Country: FR Base de données publique des médicaments Identifier(s): 60616445, 62010414
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 43550, 47639, 47817
Country: HK Department of Health Drug Office Identifier(s): 27322
Country: JP 医薬品医療機器総合機構 Identifier(s): 1119402A1022, 1119402A2029, 1119402A3033, 1119402G1025, 1119402G2021
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 311M87
Country: NG Registered Drug Product Database Identifier(s): A4-6963
Country: NL Z-Index G-Standaard, PRK Identifier(s): 44652, 44660
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 3438, 8798
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100019367
Country: US FDA, National Drug Code Identifier(s): 63323-269, 65219-800
Country: ZA Health Products Regulatory Authority Identifier(s): 31/2.1/0375, 31/2.1/0376, 36/2.1/0084, 36/2.1/0085, 36/2.1/0086, T/2.1/226, X/2.1/30, X/2.1/31

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.